These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 236823)

  • 1. Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.
    Weliky N; Leaman DH; Kallman BJ
    Cancer Res; 1975 Jun; 35(6):1580-5. PubMed ID: 236823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.
    Weliky N; Leaman DH; Kallman BJ
    J Natl Cancer Inst; 1975 Mar; 54(3):593-6. PubMed ID: 164559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.
    Weliky N; Leaman DH; Kallman BJ
    Immunology; 1975 Oct; 29(4):779-90. PubMed ID: 241721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
    Giunta S; Groppa G
    Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Epstein-Barr virus and American Burkitt's lymphoma.
    Easton JM; Ablashi DV; Levine PH; Armstrong GR
    IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
    [No Abstract]   [Full Text] [Related]  

  • 6. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
    Gunvén P
    Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
    [No Abstract]   [Full Text] [Related]  

  • 10. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody defining a Burkitt's lymphoma-associated antigen detects carbohydrate on neutral glycolipid.
    Lipinski M; Nudelman ED; Wiels J; Parsons M
    J Immunol; 1982 Nov; 129(5):2301-4. PubMed ID: 6181167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.
    Vonka V; Benyesh-Melnick M; McCombs RM
    J Natl Cancer Inst; 1970 Apr; 44(4):865-72. PubMed ID: 11515054
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.
    Guy K; Middleton PG; Docherty LJ; De Angelis CL; Steel CM
    Immunology; 1986 Dec; 59(4):603-10. PubMed ID: 3026962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.